ArticleLeukemia & lymphoma2021

Moxetumomab pasudotox as re-treatment for heavily-pretreated relapsed hairy cell leukemia.

Ilana R Yurkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.